Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00776542 · ClinicalTrials.gov registry record · NA

Bioequivalence Study of Minocycline 100mg Tablets Under Fasting Conditions

A NA study of Healthy, sponsored by Ranbaxy Laboratories Limited.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT00776542: Completed NA study of Healthy, sponsored by Ranbaxy Laboratories Limited.

NCT00776542 is a NA study of Healthy that has completed, run by Ranbaxy Laboratories Limited. The registered enrollment target is 28 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00776542, a NA study of Healthy, has completed, sponsored by Ranbaxy Laboratories Limited.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to determine the bioequivalence of Minocycline formulations after administration of single doses to normal healthy subjects under fasted conditions. These data were to be evaluated statistically to determine if the products meet bioequivalence criteria.

Conditions Studied

Interventions

  • DRUG Minocycline 100mg Tablets

Study Locations (1)

North Carolina

  • AII pharma - Chapell Hill

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2002-10
Est. Completion 2003-01
Phase NA

Sponsor

Ranbaxy Laboratories Limited

44 total trials

What the Registry Record Tells You About NCT00776542

The ClinicalTrials.gov registry entry for NCT00776542 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Ranbaxy Laboratories Limited, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Minocycline 100mg Tablets is the first listed.

NCT00776542 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00776542 about?

NCT00776542 is a clinical study titled "Bioequivalence Study of Minocycline 100mg Tablets Under Fasting Conditions". The purpose of this study was to determine the bioequivalence of Minocycline formulations after administration of single doses to normal healthy subjects under fasted conditions. These data were to be evaluated statistically to determine if the products meet bioequivalence criteria.

What is the current status of trial NCT00776542?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2002-10. Estimated completion is 2003-01.

What conditions does trial NCT00776542 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00776542?

The interventions under investigation include: Minocycline 100mg Tablets (DRUG).

Who is sponsoring clinical trial NCT00776542?

This trial is sponsored by Ranbaxy Laboratories Limited, which has 44 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00776542 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.